Harmonized Index of Consumer Prices: Pharmaceutical Products for Portugal
CP0611PTM086NEST • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
127.80
Year-over-Year Change
1.74%
Date Range
12/1/1999 - 6/1/2025
Summary
The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products in Portugal measures changes in the prices of medicines and other pharmaceutical goods consumed by Portuguese households. This metric is a key indicator of pharmaceutical inflation and a critical input for economic policy analysis.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The HICP for Pharmaceutical Products in Portugal is a component of the overall HICP, which is the primary inflation measure used by the European Union. This subindex focuses specifically on the price changes of prescription drugs, over-the-counter medications, and other pharmaceutical items purchased by consumers.
Methodology
The data is collected by Portugal's National Statistics Institute through regular surveys of retail establishments.
Historical Context
Policymakers and analysts use this HICP subindex to assess inflationary pressures in the pharmaceutical sector and inform decisions around healthcare, social welfare, and monetary policy.
Key Facts
- The HICP for Pharmaceutical Products is a component of the overall HICP in the European Union.
- Portugal's National Statistics Institute collects the data through retail surveys.
- This metric is used to assess inflationary pressures in the pharmaceutical sector.
FAQs
Q: What does this economic trend measure?
A: The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products in Portugal measures changes in the prices of medicines and other pharmaceutical goods consumed by Portuguese households.
Q: Why is this trend relevant for users or analysts?
A: This HICP subindex is a critical indicator of pharmaceutical inflation and a key input for economic policy analysis, particularly around healthcare, social welfare, and monetary policy.
Q: How is this data collected or calculated?
A: The data is collected by Portugal's National Statistics Institute through regular surveys of retail establishments.
Q: How is this trend used in economic policy?
A: Policymakers and analysts use this HICP subindex to assess inflationary pressures in the pharmaceutical sector and inform decisions around healthcare, social welfare, and monetary policy.
Q: Are there update delays or limitations?
A: The HICP for Pharmaceutical Products in Portugal is published regularly by the European Union, but there may be some delays in data availability or limitations in coverage.
Related Trends
Harmonized Index of Consumer Prices: Processed Food Including Alcohol and Tobacco for Portugal
FOODPRPTM086NEST
Infra-Annual Labor Statistics: Unemployment Male: 15 Years or over for Portugal
LFUNTTMAPTA647N
Harmonized Index of Consumer Prices: Food Products N.e.c. for Portugal
CP0119PTM086NEST
International Trade: Exports: Value (Goods): Total for Portugal
XTEXVA01PTQ188S
Producer Prices Index: Economic Activities: Manufacturing: Domestic for Portugal
PRTPPDMMINMEI
Bank's Net Interest Margin for Portugal
DDEI01PTA156NWDB
Citation
U.S. Federal Reserve, Harmonized Index of Consumer Prices: Pharmaceutical Products for Portugal (CP0611PTM086NEST), retrieved from FRED.